Contact

All Stories

  1. Comparison of Oscillometric Blood Pressure Measurements on the Arm and Forearm in Patients with Obesity, Prediabetes, and Hypertension

    Article • Diabetology, September 2025, MDPI AG

    Professor JOSE F VILELA-MARTIN

  2. New Insights on the ideal blood pressure levels for renal protection

    Article • American Journal of Hypertension, August 2025, Oxford University Press (OUP)

    Professor JOSE F VILELA-MARTIN

  3. Correlations Between Coffee Intake, Glycemic Control, Cardiovascular Risk, and Sleep in Type 2 Diabetes and Hypertension: A 12-Month Observational Study

    Article • Biomedicines, August 2025, MDPI AG

    Professor JOSE F VILELA-MARTIN

  4. A new approach to interpreting the LF/HF ratio: a study in hypertensive patients

    Article • Journal of Human Hypertension, May 2025, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  5. Electrocardiographic Left Ventricular Mass Trajectories and the Effects of Treatment in Patients at Different Stages of Hypertension

    Article • Journal of Clinical Medicine, March 2025, MDPI AG

    Professor JOSE F VILELA-MARTIN

  6. Increased arterial stiffness in normotensive individuals with hypoparathyroidism

    Article • Scientific Reports, March 2025, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  7. The correlation between age, blood pressure variability and estimated pulse wave velocity

    Article • Scientific Reports, February 2025, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  8. The effect of breakfast skipping and sleep disorders on glycemic control, cardiovascular risk, and weight loss in type 2 diabetes

    Article • Clinical Nutrition ESPEN, February 2025, Elsevier

    Professor JOSE F VILELA-MARTIN

  9. A COVID-19 E A PRESSÃO NO AMBIENTE DE TRABALHO ENFRENTADA POR PROFISSIONAIS DE SAÚDE NO CONTEXTO HOSPITALAR

    Article • January 2025, Epitaya Propriedade Intelectual e Editora LTDA

    Professor JOSE F VILELA-MARTIN

  10. The Possible Impact of COVID-19 on Glycated Hemoglobin and Systolic Blood Pressure in Type 2 Diabetes and Obesity

    Article • Obesities, October 2024, MDPI AG

    Professor JOSE F VILELA-MARTIN

  11. Demystifying Obesity: Understanding, Prevention, Treatment, and Stigmas

    Article • Nutrition Reviews, October 2024, Oxford University Press (OUP)

    Professor JOSE F VILELA-MARTIN

  12. Nutritional management, skipping breakfast, glycemic control, and cardiovascular risk on type 2 diabetes mellitus

    Article • European Heart Journal, October 2024, Oxford University Press (OUP)

    Professor JOSE F VILELA-MARTIN

  13. The Impact of a Nutritional Intervention on Glycemic Control and Cardiovascular Risk Markers in Type 2 Diabetes

    Article • Nutrients, May 2024, MDPI AG

    Professor JOSE F VILELA-MARTIN

  14. AGE AND BLOOD PRESSURE DEPENDENCY OF THREE DIFFERENT METHODS TO MEASURE PULSE WAVE VELOCITY

    Article • Journal of Hypertension, May 2024, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  15. EFFECT OF SEQUENTIAL NEPHRON BLOCKADE X DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE + BISOPROLOL IN THE TREATMENT OF RESISTANT HYPERTENSION, A RANDOMIZED CONTROLLED TRIAL (RESHYPOT)

    Article • Journal of Hypertension, May 2024, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  16. Correlation between estimated pulse wave velocity values from two equations in healthy and under cardiovascular risk populations

    Article • PLOS One, April 2024, PLOS

    Professor JOSE F VILELA-MARTIN

  17. Effects of Mindful Eating in Patients with Obesity and Binge Eating Disorder

    Article • Nutrients, March 2024, MDPI AG

    Professor JOSE F VILELA-MARTIN

  18. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023

    Article • Arquivos Brasileiros de Cardiologia, January 2024, Sociedade Brasileira de Cardiologia

    Professor JOSE F VILELA-MARTIN

  19. Brazilian Guidelines for In-office and Out-of-office Blood Pressure Measurement – 2023

    Article • Arquivos Brasileiros de Cardiologia, January 2024, Sociedade Brasileira de Cardiologia

    Professor JOSE F VILELA-MARTIN

  20. Nutritional Strategies for the Management of Type 2 Diabetes Mellitus: A Narrative Review

    Article • Nutrients, December 2023, MDPI AG

    Professor JOSE F VILELA-MARTIN

  21. Evaluation of Central Hemodynamics in the Diagnosis and Treatment of Hypertension

    Article • Current Cardiology Reviews, November 2023, Bentham Science Publishers

    Professor JOSE F VILELA-MARTIN

  22. Diretrizes Brasileiras de Medidas da Pressão Arterial Dentro e Fora do Consultório – 2023

    Article • September 2023, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  23. Abstract P378: Expression Of Micro-rna 221, 222 And 223 In Individuals Suffering From Ischemic Stroke Due To Hypertensive Emergency

    Article • Hypertension, September 2023, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  24. EXPRESSION OF MICRO-RNA 221 AND 223 IN ISCHEMIC STROKE DUE HYPERTENSIVE EMERGENCY

    Article • Journal of Hypertension, June 2023, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  25. ARTERIAL STIFFNESS IN NORMOTENSIVE PATIENTS WITH HYPOPARATHYROIDISM COMPARED TO CONTROLS

    Article • Journal of Hypertension, June 2023, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  26. SEQUENTIAL NEPHRON BLOCKADE VERSUS DUAL RENIN-ANGIOTENSIN SYSTEM BLOCKADE IN TRUE RESISTANT HYPERTENSIVE PATIENTS: A SYSTEMATIC REVIEW

    Article • Journal of Hypertension, June 2023, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  27. EVALUATION OF DEPENDENCE OF AGE AND PERIPHERAL BLOOD PRESSURE IN TWO PULSE WAVE VELOCITY ESTIMATION METHODS

    Article • Journal of Hypertension, June 2023, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  28. The Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral and Central Hemodynamic Parameters on Resistant Hypertension: A Case Report

    Article • Vascular Health and Risk Management, May 2023, Taylor & Francis

    Professor JOSE F VILELA-MARTIN

  29. The Role of Heart Rate Variability (HRV) in Different Hypertensive Syndromes

    Article • Diagnostics, February 2023, MDPI AG

    Professor JOSE F VILELA-MARTIN

  30. Effect of Sequential Nephron Blockade versus Dual Renin-Angiotensin System Blockade Plus Bisoprolol in the Treatment of Resistant Hypertension, a Randomized Controlled Trial (Resistant Hypertension on Treatment - ResHypOT)

    Article • Vascular Health and Risk Management, December 2022, Taylor & Francis

    Professor JOSE F VILELA-MARTIN

  31. Editorial: The importance of the central hemodynamic in the cardiovascular diseases development

    Article • Frontiers in Cardiovascular Medicine, October 2022, Frontiers

    Professor JOSE F VILELA-MARTIN

  32. Inflammatory cytokines are associated to lower glomerular filtration rate in patients with hypertensive crisis

    Article • Frontiers in Cardiovascular Medicine, September 2022, Frontiers

    Professor JOSE F VILELA-MARTIN

  33. Linear and non-linear analyses of autonomic modulation in uncontrolled and controlled elderly resistant hypertensives

    Article • Experimental Gerontology, March 2022, Elsevier

    Professor JOSE F VILELA-MARTIN

  34. Alterations in pro- and anti-inflammatory mediators are involved in microvascular dysfunction in postmenopausal women with type 2 diabetes mellitus

    Article • Brazilian Journal of Medical and Biological Research, January 2022, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  35. Smoking and Endothelial Dysfunction: An Integrated - Medical and Molecular Review

    Article • Medical Research Archives, January 2022, Knowledge Enterprise Journals

    Professor JOSE F VILELA-MARTIN

  36. CRISES HIPERTENSIVAS: MITOS, VERDADES E CONDUTAS

    Article • Revista da Sociedade de Cardiologia do Estado de São Paulo, October 2021, Revista da Sociedade de Cardiologia do Estado de Sao Paulo

    Professor JOSE F VILELA-MARTIN

  37. HIPERTENSÃO E DIABETES: CONCEITOS ATUAIS NA TERAPÊUTICA

    Article • Revista Brasileira de Hipertensão, September 2021, Atha Mais Editora Ltda

    Professor JOSE F VILELA-MARTIN

  38. Abstract P147: Association Between Lipid Transfer To HDL-c And Arterial Stiffness In Patients With Ischemic Stroke Due To Hypertensive Emergency

    Article • Hypertension, September 2021, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  39. Predictive Factors for Target Organ Injuries in Hypertensive Individuals

    Article • Integrated Blood Pressure Control, August 2021, Taylor & Francis

    Professor JOSE F VILELA-MARTIN

  40. RELATIONSHIP BETWEEN 24-HOURS URINARY SODIUM EXCRETION AND ARTERIAL STIFFNESS IN CONTROLLED HYPERTENSIVE AND RESISTANT HYPERTENSIVE INDIVIDUALS

    Article • Journal of Hypertension, April 2021, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  41. Diretrizes Brasileiras de Hipertensão Arterial – 2020

    Article • Arquivos Brasileiros de Cardiologia, March 2021, Sociedade Brasileira de Cardiologia

    Professor JOSE F VILELA-MARTIN

  42. Correction to: Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial

    Article • Acta Diabetologica, March 2021, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  43. Evidence of Nonadherence in Cases of Pseudoresistant Hypertension

    Article • Integrated Blood Pressure Control, February 2021, Taylor & Francis

    Professor JOSE F VILELA-MARTIN

  44. Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers

    Article • Clinics, January 2021, Fundacao Faculdade de Medicina

    Professor JOSE F VILELA-MARTIN

  45. QUAL O PAPEL DO BLOQUEIO SEQUENCIAL DO NÉFRON NA HIPERTENSÃO RESISTENTE?

    Article • Revista Brasileira de Hipertensão, December 2020, Atha Mais Editora Ltda

    Professor JOSE F VILELA-MARTIN

  46. Avaliação do Seguimento de 1 Ano dos Pacientes Incluídos no Registro da Prática Clínica em Pacientes de Alto Risco Cardiovascular (REACT)

    Article • Arquivos Brasileiros de Cardiologia, December 2020, Sociedade Brasileira de Cardiologia

    Professor JOSE F VILELA-MARTIN

  47. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial

    Article • Acta Diabetologica, October 2020, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  48. Randomized Study Comparing Vildagliptin vs Glibenclamide on Glucose Variability and Endothelial Function in Patients with Type 2 Diabetes Mellitus and Hypertension

    Article • Diabetes Metabolic Syndrome and Obesity, September 2020, Taylor & Francis

    Professor JOSE F VILELA-MARTIN

  49. Abstract P081: Expression Of Micro-rnas And Transfer Of Lipids To HDL In Vitro In Stroke Due To Hypertensive Emergency

    Article • Hypertension, September 2020, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  50. May Measurement Month 2018: an analysis of blood pressure screening results from Brazil

    Article • European Heart Journal Supplements, August 2020, Oxford University Press (OUP)

    Professor JOSE F VILELA-MARTIN

  51. Posicionamento Luso-Brasileiro de Emergências Hipertensivas – 2020

    Article • Arquivos Brasileiros de Cardiologia, April 2020, Sociedade Brasileira de Cardiologia

    Professor JOSE F VILELA-MARTIN

  52. Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis

    Article • BMC Cardiovascular Disorders, March 2020, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  53. Posicionamento Brasileiro sobre Hipertensão Arterial Resistente – 2020

    Article • Arquivos Brasileiros de Cardiologia, January 2020, Sociedade Brasileira de Cardiologia

    Professor JOSE F VILELA-MARTIN

  54. Effect of a Multifaceted Quality Improvement Intervention on the Prescription of Evidence-Based Treatment in Patients at High Cardiovascular Risk in Brazil

    Article • JAMA Cardiology, May 2019, American Medical Association (AMA)

    Professor JOSE F VILELA-MARTIN

  55. Central Hemodynamic Parameters are Altered in Resistant Hypertensive Individuals

    Article • Artery Research, January 2019, Atlantis Press

    Professor JOSE F VILELA-MARTIN

  56. CRISES HIPERTENSIVAS: DEFININDO A GRAVIDADE E O TRATAMENTO

    Article • Revista da Sociedade de Cardiologia do Estado de São Paulo, September 2018, Revista da Sociedade de Cardiologia do Estado de Sao Paulo

    Professor JOSE F VILELA-MARTIN

  57. Effect of vildagliptin versus glibenclamide on endothelial function and arterial stiffness in patients with type 2 diabetes and hypertension: a randomized controlled trial

    Article • Acta Diabetologica, August 2018, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  58. CIRCULATING LEVELS OF MATRIX METALLOPROTEINASE-9 ARE ELEVATED IN INDIVIDUALS WITH HYPERTENSIVE CRISIS

    Article • Journal of Hypertension, June 2018, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  59. INFLUENCE OF ANTIHYPERTENSIVE TREATMENT ON MMP-9 LEVELS IN CONTROLLED HYPERTENSIVE INDIVIDUALS

    Article • Journal of Hypertension, June 2018, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  60. Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension

    Article • Journal of Hypertension, April 2018, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  61. Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?

    Article • Current Hypertension Reports, March 2018, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  62. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension – study protocol for a randomized cont...

    Article • Trials, February 2018, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  63. Prevalence of Physical Inactivity and its Effects on Blood Pressure and Metabolic Parameters in a Brazilian Urban Population

    Article • International Journal of Cardiovascular Sciences, January 2018, Sociedade Brasileira de Cardiologia

    Professor JOSE F VILELA-MARTIN

  64. Do thiazide diuretics reduce central systolic blood pressure in hypertension?

    Article • Journal of Clinical Hypertension, November 2017, Wiley

    Professor JOSE F VILELA-MARTIN

  65. Guidelines on the management of arterial hypertension and related comorbidities in Latin America

    Article • Journal of Hypertension, August 2017, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  66. Effects of acute blood pressure elevation on biochemical-metabolic parameters in individuals with hypertensive crisis

    Article • Clinical and Experimental Hypertension, June 2017, Taylor & Francis

    Professor JOSE F VILELA-MARTIN

  67. Vascular Peripheric Differences In Patients With Chagas Versus Ischemic Heart Failure

    Article • Medicine & Science in Sports & Exercise, May 2017, Wolters Kluwer Health

    Dr Gaspar R Chiappa, Professor JOSE F VILELA-MARTIN

  68. I Luso-Brazilian Positioning on Central Arterial Pressure

    Article • Arquivos Brasileiros de Cardiologia, January 2017, Sociedade Brasileira de Cardiologia

    Professor JOSE F VILELA-MARTIN

  69. Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial

    Article • Journal of the American Heart Association, December 2016, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  70. Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin

    Article • Hypertension, September 2016, Wolters Kluwer Health

    Professor Yuriy M. Sirenko, Professor JOSE F VILELA-MARTIN

  71. [PP.21.02] INDIVIDUALS WITH HYPERTENSIVE EMERGENCY PRESENT ASSOCIATION BETWEEN RENAL DYSFUNCTION AND INFLAMMATORY CYTOKINES

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  72. [PP.36.12] METABOLIC CHANGES, BIOMARKERS OF ENDOTHELIAL DYSFUNCTION AND COAGULATION FACTORS ARE PRESENT IN INDIVIDUALS WITH HYPERTENSIVE CRISIS

    Article • Journal of Hypertension, September 2016, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  73. Endothelial Changes in Individuals with Prehypertension

    Article • Current Hypertension Reviews, May 2016, Bentham Science Publishers

    Professor JOSE F VILELA-MARTIN

  74. How to Investigate the Vascular Changes in Resistant Hypertension

    Article • Current Hypertension Reviews, May 2016, Bentham Science Publishers

    Professor JOSE F VILELA-MARTIN

  75. Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date

    Article • Drug Design Development and Therapy, May 2016, Dove Medical Press

    Professor JOSE F VILELA-MARTIN

  76. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension

    Article • Journal of Hypertension, April 2016, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  77. Effects of transcutaneous electrical nerve stimulation (TENS) on arterial stiffness and blood pressure in resistant hypertensive individuals: study protocol for a randomized controlled trial

    Article • Trials, March 2016, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  78. Chlorthalidone Plus Amiloride Reduces the Central Systolic Blood Pressure in Stage 1 Hypertension Patients

    Article • Cardiology Research, January 2016, Elmer Press, Inc.

    Professor JOSE F VILELA-MARTIN

  79. Angiotensin-converting enzyme insertion/deletion polymorphism, 24-h blood pressure profile and left ventricular hypertrophy in hypertensive individuals: a cross-sectional study

    Article • European Journal of Medical Research, September 2015, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  80. Twelve-week randomized study to compare the effect of vildagliptin vs. glibenclamide both added-on to metformin on endothelium function in patients with type 2 diabetes and hypertension

    Article • Diabetology & Metabolic Syndrome, August 2015, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  81. DPP-4 Inhibitor Reduces Central Blood Pressure in a Diabetic and Hypertensive Patient

    Article • Medicine, July 2015, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  82. PP.28.15

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  83. PP.20.30

    Article • Journal of Hypertension, June 2015, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  84. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

    Article • The Lancet, May 2015, Elsevier

    Professor Yuriy M. Sirenko, Professor JOSE F VILELA-MARTIN

  85. Effect of transcutaneous electrical nerve stimulation on peripheral to central blood pressure ratio in healthy subjects

    Article • Clinical Physiology and Functional Imaging, January 2015, Wiley

    Professor JOSE F VILELA-MARTIN, Dr Gaspar R Chiappa

  86. Blockade of Renin Angiotensin System in Heart Failure Post-Myocardial Infarction: What is the Best Therapy?

    Article • Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery), January 2015, Bentham Science Publishers

    Professor JOSE F VILELA-MARTIN

  87. Prevalence of Metabolic Syndrome: Association with Risk Factors and Cardiovascular Complications in an Urban Population

    Article • PLOS One, September 2014, PLOS

    Professor JOSE F VILELA-MARTIN

  88. Is There an Association between Periodontitis and Hypertension?

    Article • Current Cardiology Reviews, July 2014, Bentham Science Publishers

    Professor JOSE F VILELA-MARTIN

  89. Nebivolol reduces central blood pressure in stage I hypertensive patients: experimental single cohort study

    Article • Sao Paulo Medical Journal, January 2014, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  90. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

    Article • New England Journal of Medicine, October 2013, New England Journal of Medicine (NEJM/MMS)

    Professor JOSE F VILELA-MARTIN, Filipa Costa, Professor Yuriy M. Sirenko, Massimo Volpe, Professor Dragan B Djordjevic, luigi gnudi

  91. Renin Angiotensin System Blockage Associates with Insertion/Deletion Polymorphism of Angiotensin-Converting Enzyme in Patients with Hypertensive Emergency

    Article • DNA and Cell Biology, September 2013, Mary Ann Liebert Inc

    Professor JOSE F VILELA-MARTIN

  92. Evidence-Based Therapy Prescription in High-Cardiovascular Risk Patients: The REACT Study

    Article • Arquivos Brasileiros de Cardiologia, January 2013, GN1 Genesis Network

    Professor JOSE F VILELA-MARTIN

  93. Carotid intima-media thickness is associated with cognitive deficiency in hypertensive patients with elevated central systolic blood pressure

    Article • Cardiovascular Ultrasound, October 2012, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  94. I posicionamento brasileiro sobre hipertensão arterial resistente

    Article • Arquivos Brasileiros de Cardiologia, July 2012, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  95. Urinary albumin excretion regression in hypertensive individuals

    Article • International Journal of Cardiology, May 2012, Elsevier

    Professor JOSE F VILELA-MARTIN

  96. Hyperglycemia in patients with hypertensive crisis: Response to “Hypertensive crisis: Comparison between diabetics and non-diabetics”

    Article • International Journal of Cardiology, February 2012, Elsevier

    Professor JOSE F VILELA-MARTIN

  97. Fatores associados ao aumento no índice de incremento de pressão radial em indivíduos hipertensos

    Article • Arquivos Brasileiros de Cardiologia, September 2011, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  98. Gene Variation in Resistant Hypertension: Multilocus Analysis of the Angiotensin 1-Converting Enzyme, Angiotensinogen, and Endothelial Nitric Oxide Synthase Genes

    Article • DNA and Cell Biology, August 2011, Mary Ann Liebert Inc

    Professor JOSE F VILELA-MARTIN, Jose Krieger

  99. Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension

    Article • Journal of Human Hypertension, May 2011, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  100. Is There An Association Between Vitamin D and Hypertension?

    Article • Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery), May 2011, Bentham Science Publishers

    Professor JOSE F VILELA-MARTIN

  101. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial

    Article • Trials, March 2011, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  102. A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial

    Article • Trials, February 2011, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  103. Hypertensive crisis: clinical–epidemiological profile

    Article • Hypertension Research, December 2010, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  104. Factors associated with impaired urinary albumin excretion in hypertensive individuals

    Article • International Journal of Cardiology, November 2010, Elsevier

    Professor JOSE F VILELA-MARTIN

  105. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness

    Article • Journal of Human Hypertension, October 2010, Springer Science + Business Media

    Professor JOSE F VILELA-MARTIN

  106. Metabolic Abnormalities Are Associated with Blood Pressure Control.

    Article • June 2010, Endocrine Society

    Professor JOSE F VILELA-MARTIN

  107. UNCONTROLLED AND CONTROLLED RESISTANT HYPERTENSION: REALLY ONLY ONE HYPERTENSIVE CONDITION?: PP.34.412

    Article • Journal of Hypertension, June 2010, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  108. Prevalência e fatores de risco para hipertensão em uma população urbana brasileira

    Article • Arquivos Brasileiros de Cardiologia, April 2010, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  109. ARTERIAL AND VENOUS ENDOTHELIAL DYSFUNCTION IN RESISTANT HYPERTENSIVE PATIENTS

    Article • Journal of the American College of Cardiology, March 2010, Elsevier

    Professor JOSE F VILELA-MARTIN

  110. Coronary emergency and diabetes as manifestations of pheochromocytoma

    Article • International Journal of Cardiology, March 2010, Elsevier

    Professor JOSE F VILELA-MARTIN

  111. Ausência de descenso noturno se associa a acidente vascular cerebral e infarto do miocárdio

    Article • Arquivos Brasileiros de Cardiologia, January 2010, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  112. Evaluation of the awareness, control and cost-effectiveness of hypertension treatment in a Brazilian city: populational study

    Article • Journal of Hypertension, September 2009, Wolters Kluwer Health

    Professor JOSE F VILELA-MARTIN

  113. H 027 Multifactorial Evaluation of the Interaction of Polymorphisms of Raas Genes and Nitric Oxide Endothelial Synthase in Resistant and Controlled Hypertensive Patients

    Article • Atherosclerosis Supplements, August 2009, Elsevier

    Jose Krieger, Professor JOSE F VILELA-MARTIN

  114. H 025 Concentric left Ventricular Hypertrophy as an Early Marker of Cardiovascular Risk in Resistant Hypertension

    Article • Atherosclerosis Supplements, August 2009, Elsevier

    Professor JOSE F VILELA-MARTIN

  115. H 005 Hypertensive Crisis: Clinical and Epidemiological Profile

    Article • Atherosclerosis Supplements, August 2009, Elsevier

    Professor JOSE F VILELA-MARTIN

  116. H 004 Nondipper is Associated with Stroke and Myocardial Infarction

    Article • Atherosclerosis Supplements, August 2009, Elsevier

    Professor JOSE F VILELA-MARTIN

  117. H 008 Predictors of In-hospital Mortality in Patients Admitted to Hospital Emergency Presenting Hypertensive Crisis

    Article • Atherosclerosis Supplements, August 2009, Elsevier

    Professor JOSE F VILELA-MARTIN

  118. H 015 Simultaneous Evaluation of Endothelial Function and Velocity of Wave Pulse in Resistant Hypertensive Patients

    Article • Atherosclerosis Supplements, August 2009, Elsevier

    Professor JOSE F VILELA-MARTIN

  119. Factors associated to patients' noncompliance with hypertension treatment

    Article • Revista Latino-Americana de Enfermagem, April 2009, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  120. Dissecção aguda de aorta como apresentação de emergência hipertensiva

    Article • Brazilian Journal of Cardiovascular Surgery, December 2008, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  121. Prevalência e fatores sociodemográficos em hipertensos de São José do Rio Preto - SP

    Article • Arquivos Brasileiros de Cardiologia, July 2008, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  122. Disfunção cognitiva após cirurgia cardíaca

    Article • Brazilian Journal of Cardiovascular Surgery, June 2008, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  123. H 023 α-ADDUCIN GENETIC VARIANTS AND RISK FACTORS IN SYSTEMIC HYPERTENSION

    Article • Atherosclerosis Supplements, June 2007, Elsevier

    Professor JOSE F VILELA-MARTIN

  124. H 031 THE PREVALENCE OF METABOLIC SYNDROME IN PATIENTS SUFFERING FROM HYPERTENSIVE CRISES

    Article • Atherosclerosis Supplements, June 2007, Elsevier

    Professor JOSE F VILELA-MARTIN

  125. H 024 POLYMORPHISMS OF THE ACE INSERTION/DELETION, M235T ANGIOTENSINOGEN AND ENOS GLU298ASP GENES IN REFRACTORY HYPERTENSION

    Article • Atherosclerosis Supplements, June 2007, Elsevier

    Professor JOSE F VILELA-MARTIN

  126. H 025 EVALUATION OF ENDOTHELIAL FUNCTION AND VASCULAR THICKNESS IN REFRACTORY HYPERTENSIVE PATIENTS

    Article • Atherosclerosis Supplements, June 2007, Elsevier

    Professor JOSE F VILELA-MARTIN

  127. H 026 CARDIOVASCULAR REMODELING (CONCENTRIC LEFT VENTRICLE HYPERTROPHY AND INCREASE IN THE INTIMA-MEDIA THICKNESS) IN REFRACTORY HYPERTENSION

    Article • Atherosclerosis Supplements, June 2007, Elsevier

    Professor JOSE F VILELA-MARTIN

  128. H 029 ACE GENETIC POLYMORPHISMS IN PATIENTS SUFFERING HYPERTENSIVE CRISES

    Article • Atherosclerosis Supplements, June 2007, Elsevier

    Professor JOSE F VILELA-MARTIN

  129. H 036 CARDIOVASCULAR RISK STRATIFICATION IN PATIENTS WITH REFRACTORY ARTERIAL HYPERTENSION

    Article • Atherosclerosis Supplements, June 2007, Elsevier

    Professor JOSE F VILELA-MARTIN

  130. Alike the metabolic syndrome, hypertension is more than just increased blood pressure

    Article • European Heart Journal, February 2006, European Society of Cardiology

    Professor JOSE F VILELA-MARTIN

  131. Infarto agudo do miocárdio e dissecção aguda de aorta: um importante diagnóstico diferencial

    Article • Brazilian Journal of Cardiovascular Surgery, December 2004, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  132. Perfil de crise hipertensiva: prevalência e apresentação clínica

    Article • Arquivos Brasileiros de Cardiologia, August 2004, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  133. Adenoma de Conn: uma causa de hipertensão e hipocalemia

    Article • Arquivos Brasileiros de Cardiologia, July 2004, FapUNIFESP (SciELO)

    Professor JOSE F VILELA-MARTIN

  134. Introduction and basic concepts

    Article • September 2000, World Scientific Pub Co Pte Lt

    Professor JOSE F VILELA-MARTIN